| Company Name: | Kyphon Incorporated | | Ticker Symbol: | KYPH | | | WWW Address: | www.kyphon.com | | CEO: | Richard W. Mott | | No. of Employees: | 1,090 | | Common Issue Type: | CS | | Business Description: | A medical device company deals in the design, manufacture and marketing of medical devices to treat and restore spinal anatomy using minimally invasive technology.
|
| | | Industry Information: | HEALTH SERVICES - Medical Instruments & Supplies [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | |  | - | - | 0 | 71.02 | 70.81 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 3,257.8 | 45.9 | 1.10 | 0.86 | 0.00 | 354.9 | 0.0 | 71.50 - 32.98 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 70.97 | $ | | PE Ratio - LTM | 354.9 | |
| Market Capitalisation | 3,257.8 | mil |
| Latest Shares Outstanding | 45.9 | mil |
| Earnings pS (EPS) | 0.86 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 374,119 | $ |
| Effective Tax Rate | 43.8 | % |
| Float | 45.6 | mil |
| Float as % of Shares Outstanding | 99.3 | % |
| Foreign Sales | 84 | mil |
| Domestic Sales | 324 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 61.50 | % |
| Research & Devlopment (R&D) as % of Revenue | 9.60 | % |
| Gross Profit Margin | 89.7 | % |
| EBITDA Margin | 18.7 | % |
| Pre-Tax Profit Margin | 7.2 | % |
| Assets Turnover | 0.8 | % |
| Return on Assets (ROA) | 1.1 | % |
| Return on Equity (ROE) | 3.0 | % |
| Return on Capital Invested (ROCI) | 1.4 | % |
| Current Ratio | 2.2 | |
| Leverage Ratio (Assets/Equity) | 2.7 | |
| Interest Cover | 3.3 | |
| Total Debt/Equity (Gearing Ratio) | 1.19 | |
| LT Debt/Total Capital | 54.0 | % |
| Working Capital pS | 2.31 | $ |
| Cash pS | 1.13 | $ |
| Book-Value pS | 7.32 | $ |
| Tangible Book-Value pS | -4.89 | $ |
| Cash Flow pS | 0.80 | $ |
| Free Cash Flow pS | -11.54 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 9.70 | |
| Price/Tangible Book Ratio | -14.51 | |
| Price/Cash Flow | 88.7 | |
| Price/Free Cash Flow | -6.1 | |
| P/E as % of Industry Group | 1,334.0 | % |
| P/E as % of Sector Segment | 571.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.0 | 101 | 8,251 | 0 |
| 4 Weeks | 71.50 | 70.34 | 70.56 | 0.6 | 105 | 8,581 | 137,295 |
| 13 Weeks | 71.50 | 63.24 | 65.93 | 7.6 | 104 | 8,005 | 480,284 |
| 26 Weeks | 71.50 | 44.85 | 45.96 | 54.4 | 155 | 9,732 | 1,197,058 |
| 52 Weeks | 71.50 | 32.98 | 34.45 | 106.0 | 189 | 8,786 | 2,161,300 |
| YTD | 71.50 | 40.14 | - | 75.7 | 166 | 8,624 | 1,836,893 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 70.90 | 70.83 | 69.45 | 58.24 | 54.82 | 1.10 | -0.08 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 53.21 | 95.9 | 32.80 |
| Income | 0.00 | 0.0 | -12.95 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 95.11 | NA | 91.02 |
| R&D | 40.99 | NA | 33.10 |
| Normalized Inc. | 0.00 | NA | 7.39 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 41.5 | 42.8 | 33.2 |
| Earnings % | -100.0 | 15.8 | 33.2 |
| EPS % | -100.0 | 9.5 | 30.3 |
| EPS $ | -0.65 | 0.02 | 0.20 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 53.21 |
| Current Ratio | 4.1 |
| Quick Ratio (Acid Test) | 3.8 |
| Liquidity Ratio (Cash) | 2.75 |
| Receivables Turnover | 6.3 |
| Average Collection Period | 57 |
| Working Capital/Equity | 66.2 |
| Working Capital pS | 5.07 |
| Cash-Flow pS | 1.03 |
| Free Cash-Flow pS | -0.43 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 25.61 |
| Financial Leverage Ratio (Assets/Equity) | 1.2 |
| Debt Ratio | 19.6 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 3.0 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.00 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 12.30 |
| Tobin's Q Ratio | 7.60 |
| Current P/E Ratio - LTM | 354.90 |
| Enterprise Value (EV)/EBITDA | 46.23 |
| Enterprise Value (EV)/Free Cash Flow | -179.55 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -14.51 |
| Price/Book Ratio - LTM | 9.70 |
| Price/Cash Flow Ratio | 88.7 |
| Price/Free Cash Flow Ratio - LTM | -6.1 |
| Price/Sales Ratio | 6.68 |
| P/E Ratio (1 month ago) - LTM | 351.4 |
| P/E Ratio (26 weeks ago) - LTM | 53.4 |
| P/E Ratio (52 weeks ago) - LTM | 46.6 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 1,334.0 |
| P/E as % of Sector Segment | 571.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 114.5 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 1.63 |
| Tangible Book Value pS - LTM | -4.89 |
| Book Value pS - LTM | 7.32 |
| Capital Invested pS | 7.51 |
| Cash pS - LTM | 1.13 |
| Cash Flow pS - LTM | 0.80 |
| Free Cash Flow pS - LTM | -11.54 |
| Earnings pS (EPS) | 0.86 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -4.73 |
| Free Cash Flow Margin 5YEAR AVG | 5.01 |
| Net Profit Margin | 9.7 |
| Net Profit Margin - 5YEAR AVRG. | 9.1 |
| Equity Productivity | 1.18 |
| Return on Equity (ROE) | 11.5 |
| Return on Equity (ROE) - 5YEAR AVRG. | 10.3 |
| Capital Invested Productivity | 1.18 |
| Return on Capital Invested (ROCI) | 11.5 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 10.3 |
| Assets Productivity | 1.10 |
| Return on Assets (ROA) | 9.3 |
| Return on Assets (ROA) - 5YEAR AVRG. | 8.5 |
| Gross Profit Margin | 89.7 |
| Gross Profit Margin - 5YEAR AVRG. | 90.6 |
| EBITDA Margin - LTM | 18.7 |
| EBIT Margin - LTM | 10.4 |
| Pre-Tax Profit Margin | 17.3 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 13.4 |
| Effective Tax Rate | 43.8 |
| Effective Tax Rate - 5YEAR AVRG. | 3.2 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 149 |
| Revenue per Employee | 374,119 |
| Net Income per Employee | 36,451 |
| Average Collection Period | 65 |
| Receivables Turnover | 6.3 |
| Day's Inventory Turnover Ratio | 84 |
| Inventory Turnover | 4.3 |
| Inventory/Sales | 2.9 |
| Accounts Payble/Sales | 2.56 |
| Assets/Revenue | 0.91 |
| Net Working Capital Turnover | 1.79 |
| Fixed Assets Turnover | 3.21 |
| Total Assets Turnover | 1.1 |
| Revenue per $ Cash | 4.98 |
| Revenue per $ Plant | 14.78 |
| Revenue per $ Common Equity | 1.18 |
| Revenue per $ Capital Invested | 1.18 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 62.4 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 62.4 |
| Research & Devlopment (R&D) as % of Revenue | 9.8 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 9.8 |
|
|  
|
| |
 |  |